en
European Commission
>
Research
>
Health >
Infectious Diseases
Contact
|
Search on Europa
Homepage
General information
RTD Infectious Diseases Unit
Developing countries
EDCTP
Projects
About FP6 Funding
FP6 projects
About FP5 Funding
FP5 projects
Search projects
Addressed Diseases
HIV/AIDS
-
News
Malaria
Tuberculosis
Calls for proposals
FP7 Calls
Contact corner
Unit
Scientific officers
Subscribe to our mailing list
Search Projects
Free Search
Search By Keywords
Select a keyword
1-deoxy-D-xylulose 5-phosphate
2-C-methyl-D-erythritol-4-phosphate
3-D structure
3Dstructure
ACC
adjuvant
adverse effects
age
AIDS
AIDS vaccine
animal models
Anopheles
antagonist
anti-HIV treatment
anti-phospholipid
anti-retroviral therapy
antigens
antimalarial
antimalarial drug development
antimetabolites
antiretroviral
antiretroviral therapy
antiretroviral therapy
antiretroviral therapy (ART)
antiviral agents
antiviral drugs
antiviral therapy
apoptosis
aquaglyceroporin
artesunate
assay development
assay systems
Babesia
basic research
Beijing genotype
biochemistry
bioinformatics
blockade
cAMP
capacity building
CD4
CD4 T cells to HIV CD8 T cell to HIV
CD8
cell signalling
cellular co-factors
cellular factors
cellular immune response
central nervous system
chemical library screenings
chemistry
chemotherapy
childhood
children
China
chloroquine resistance
chromatin
clade C
clinical outcome
clinical study
clinical trial
clinical trials
cohort
combination therapy
combinatorial methods in life sciences
comparative genomics
complement
correlates of protection vaccine discovery
Crystal structure
crystallography
cytoadhesion
cytochromes P450
cytokine
DABOs
data-mining in proteins
database
dendritic cell-based vaccine
dendritic cells
developing countries
development
development pharmacology
dimerisation
dissemination
diversity
DNA
DNA chips
DNA fingerprinting
DNA vaccine
dormancy
DOXP
drug
drug resistance
drug candidate
drug design
drug development
drug discovery
drug resistance
drug targets
drug-resistance
Eastern Europe
emergency treatment
entry
Env
epidemiology
error catastrophe
Europe
external quality assurance
feline immunodeficiency virus (FIV)
fitness
flow cytometry
fluoroquinolones
forward genetics
gametocyte
gene therapy
genetic cross
genetics
genome scanning
genomic
genomics
HAART
HBHA
health
high-throughput screening
hit-to-lead optimisation
HIV
HIV drug resistance
HIV entry
HIV infection
HIV neutralising antibodies
HIV RNA
HIV treatment
HIV vaccine
HIV-1
HIV-1 subtypes B and C
HIV-1 vaccine
HIV-1/MuLV model
HIV-Vaccines
HIV/AIDS
HT-screening
HTS
human immunodeficiency virus
human immunodeficiency virus (HIV)
Human parasitology
humanised mice
immune markers
immune therapy
Immunity
immunodeficiencies
immunogenic epitopes
immunogenicity. cohort
Immunology
immunopathology
immunostimulatory drug
Immunotherapy
incidence
infant
infection
Infections
inhibitor design
inhibitors
innate immune responses
innovative Redox concept
integrase
integrated project
integration
Internal cooperation
interventions
iron-sulphur-cluster
isoprenoid
isoprenoid biosynthesis
key mutations
latency
Latent tuberculosis
lead compounds
Life sciences
live attenuated vaccine
live vaccines
liver
liver stage
lymph node
macaques
macrophages
Malaria
malaria chemotherapy
management
MC 1220
MDR-TB
measles virus vector
mechanism of action
medicinal chemistry
medicine
MEP
microarray
Microbicide
Microbicides
modelling
molecular biology methods
molecular detection
molecular epidemiology
molecular genetics
molecular typing
Mother-to-child transmission
mucosal
Mucosal immunity
mucosal vaccination
Mucosal vaccines
multi-drug resistance
multidrug resistance
multidrug resistant TB
multidrug-resistance
mycobacteria
Mycobacterium tuberculosis
mycolic acid pathway
Nef
neonatal
Neutralising Antibodies
neutralising antibody
new drugs
NMR
NNRTIs
non-human primates
nonnucleoside reverse transcriptase inhibitors (NNRTIs)
nucleocapsid
nucleoside RT inhibitors (NRTIs)
NYVAC
NYVAC- MVA â ELISPOT
observational
observational study
P. falciparum
paediatric
pathogenicity
pharmaceutical chemistry
pharmacokinetic studies.
phase I clinical trials
phase I HIV vaccine trial
phase IIa clinical trial
phospholipid
Phospholipid metabolism
plant-made pharmaceuticals
plantibodies
plantigens
Plasmodium
Plasmodium falciparum
Plasmodium vivax
poverty related diseases
pregnancy
prevention
primary resistance
prime boost strategies
prime-boost
prime-boost HIV vaccine
prognostics
progression
protease inhibitor
protection
protein and nucleotide kinases
protein kinase A type I (PKAI)
protein phosphorylation
Protein structure
protein vaccine
protein/RNA interaction
proteomics and linkage maps
rabies
rapid methods
rational design of inhibitors
Rational drug design
reactivation
Reagents
reccombinant attenuated pox virus
recombinant measles virus
reductoisomerase
regulatory genes
replication capacity
resistance
reverse transcriptase
rifampicin
RNA aptamers
RT-FHIV
safety
scientific research
screening
Screening assays
SELEX
sensor array
seroconverters
Severe malaria
SFV
SFV/DNA vaccine
SHIV
SHIV model
signal transduction pathways
single nucleotide polymorphisms
siRNA
SIV
SNP
social aspects
sporozoite
SPREAD
standardisation
structure-function analysis
sub-type
sub-unit vaccines
subtype
SuPAR
suppository
surveillance
survival
T lymphocyte
T lymphocytes
T-cell immunology
T-cells
T-helper cells
T-regulatory cells
target
Tat protein
Tat-Env complex
therapeutic vaccine
thymus
Toll-like receptors
training
transcriptional profiling
transgenic mice
Transgenic plants
transmission
treatment
treatment efficacy marker
Tuberculosis
type I interferons
Vaccination
vaccine
vaccine development
Vaccine network
vaccines
vaccinia virus recombinant vaccine vectors
vaginal
vertical transmission
viral factors
viral fitness
viral load
viral release
viral vector
virology
virosome
virulence
virus entry
vitamin B6
vitamine biosynthesis
VNTR typing
WHO
women
X-ray crystallography
Free search
List by
Framework Programme:
FP5
,
FP6
Diseases:
Malaria
,
HIV / AIDS
,
Tuberculosis
Year:
1998
,
2000
,
2001
,
2002
,
2003
,
2004
,
2005
,
2006
,
2007
Coordinator's Country:
Austria - AT
Belgium - BE
Switzerland - CH
Germany - DE
Denmark - DK
Spain - ES
Finland - FI
France - FR
Hungary - HU
Ireland - IE
Italy - IT
Netherlands (The) - NL
Norway - NO
Poland - PL
Portugal - PT
Sweden - SE
Senegal - SN
Thailand - TH
United Kingdom - UK
Project Coordinator:
List
